Biocon to start selling breast cancer drug in India in February

January 18, 2014 9:56 AM

5 0

Biocon to start selling breast cancer drug in India in February

MUMBAI (Reuters) - Biocon Ltd said its generic version of Roche's Herceptin breast cancer treatment would be available to patients in India from the first week of February.

Bangalore-based Biocon jointly developed biosimilar trastuzumab, which received the Indian drug regulator's marketing approval in November, with U.S.-based Mylan Inc.

Read more

To category page

Loading...